NASDAQ | TSX: ACB
Your vote is important no matter how many
shares you own. Please vote today.
Shareholders with questions or who need
assistance voting their shares should contact Aurora's
strategic advisor and
proxy solicitation agent, Laurel Hill Advisory Group (Toll-Free
Tel: 1-877-452-7184 / International Tel:
1-416-304-0211
E-mail:
assistance@laurelhill.com)
EDMONTON, AB, July 30,
2024 /PRNewswire/ - Aurora Cannabis Inc.
(the "Company" or "Aurora") (NASDAQ: ACB) (TSX:
ACB), a leading Canada-based
global medical cannabis company, would like to remind its
shareholders of the Company's upcoming annual general and special
meeting that will be held on Friday August
9, 2024 at 1:00 p.m. Eastern
Time / 11:00 a.m. Mountain
Time live webcast at: https://meetnow.global/MRZ2RL5
(the "Meeting").
Shareholders are advised to vote their shares well in advance of
the proxy voting deadline of Wednesday
August 7, 2024 at 1:00 p.m. Eastern
Time / 11:00 a.m. Mountain
Time.
YOUR VOTE IS IMPORTANT NO MATTER HOW MANY
SHARES YOU HOLD
THE BOARD OF DIRECTORS RECOMMENDS THAT
SHAREHOLDERS VOTE FOR ALL DIRECTOR NOMINEES AND PROPOSED
RESOLUTIONS
Shareholders are encouraged to read the Meeting materials,
available on the Company's website at
www.auroramj.com/investors/corporate-governance as well as under
Aurora's profile on SEDAR+ (www.sedarplus.ca). In the interest of
time, shareholders may vote online or by telephone in accordance
with the voting instructions found on their form of proxy or voting
instruction form.
Shareholder Questions or Voting Assistance: Shareholders
who have questions or require assistance with voting may contact
the Aurora's proxy solicitation agent and shareholder
communications advisor:
Laurel Hill Advisory Group
Toll Free:
1-877-452-7184 (for shareholders in North
America)
International: +1 416-304-0211 (for shareholders outside
Canada and the US)
Email: assistance@laurelhill.com
About Aurora
Aurora is opening the world to cannabis, serving both the
medical and consumer markets across Canada, Europe, Australia and South
America. Headquartered in Edmonton, Alberta, Aurora is a pioneer in
global cannabis, dedicated to helping people improve their lives.
The Company's adult-use brand portfolio includes Drift, San Rafael
'71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis
brands include MedReleaf, CanniMed, Aurora and Whistler Medical
Marijuana Co, as well as international brands, Pedanios, Bidiol,
IndiMed and CraftPlant. Aurora also has a controlling interest in
Bevo Farms Ltd., North America's
leading supplier of propagated agricultural plants. Driven by
science and innovation, and with a focus on high-quality cannabis
products, Aurora's brands continue to break through as industry
leaders in the medical, wellness and adult recreational markets
wherever they are launched. Learn more at www.auroramj.com and
follow us
on X and LinkedIn.
Aurora's common shares trade on the NASDAQ and TSX under the
symbol "ACB".
Forward Looking Statements
This news release includes statements containing certain
"forward looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. Forward-looking statements made in this news
release include statements regarding the Meeting, including the
time and how to participate.
These forward-looking statements are only predictions. Forward
looking information or statements contained in this news release
have been developed based on assumptions management considers to be
reasonable. Material factors or assumptions involved in developing
forward-looking statements include, without limitation, publicly
available information from governmental sources as well as from
market research and industry analysis and on assumptions based on
data and knowledge of this industry which the Company believes to
be reasonable. Forward-looking statements are subject to a variety
of risks, uncertainties and other factors that management believes
to be relevant and reasonable in the circumstances could cause
actual events, results, level of activity, performance, prospects,
opportunities or achievements to differ materially from those
projected in the forward-looking statements. These risks include,
but are not limited to, the ability to retain key personnel, the
ability to continue investing in infrastructure to support growth,
the ability to obtain financing on acceptable terms, the continued
quality of our products, customer experience and retention, the
development of third party government and nongovernment consumer
sales channels, management's estimates of consumer demand
in Canada and in jurisdictions where the Company exports,
expectations of future results and expenses, the risk of successful
integration of acquired business and operations, management's
estimation that SG&A will grow only in proportion of revenue
growth, the ability to expand and maintain distribution
capabilities, the impact of competition, the general impact of
financial market conditions, the yield from cannabis growing
operations, product demand, changes in prices of required
commodities, competition, and the possibility for changes in laws,
rules, and regulations in the industry, epidemics, pandemics or
other public health crises, and other risks, uncertainties and
factors set out under the heading "Risk Factors" in the Company's
annual information form dated June 20, 2024 (the "AIF")
and filed with Canadian securities regulators available on the
Company's issuer profile on SEDAR
at www.sedarplus.com and filed with and available on the
SEC's website at www.sec.gov. The Company cautions that the
list of risks, uncertainties and other factors described in the AIF
is not exhaustive and other factors could also adversely affect its
results. Readers are urged to consider the risks, uncertainties and
assumptions carefully in evaluating the forward-looking statements
and are cautioned not to place undue reliance on such information.
The Company is under no obligation, and expressly disclaims any
intention or obligation, to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise, except as expressly required by applicable securities
law.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/aurora-cannabis-inc-reminds-shareholders-to-vote-in-advance-of-the-proxy-voting-deadline-for-its-2024-annual-general-and-special-meeting-of-shareholders-302209444.html
SOURCE Aurora Cannabis Inc.